External Source

A Phase 1 Study Of Amg 701 In Subjects With Relapsed/refractory Multiple Myeloma

2020 9:44
Synopsis
A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® ...

You Might Also Like

Simon Harrison: Early Data on AMG 701 for Heavily Pretreated Relapsed/Refractory Multiple Myeloma 3:12
Simon Harrison: Early Data On Amg 701 For Heavily Pretreated...
2020
AMG 701 shows promise in heavily pre-treated myeloma patients 1:30
Amg 701 Shows Promise In Heavily Pre-treated Myeloma Patient...
2021
How does BiTE® AMG 701 compare to other immunotherapies for heavily pretreated patients? 4:31
How Does Bite® Amg 701 Compare To Other Immunotherapies For...
2021
AMG 420 and AMG 701 in R/R myeloma 2:11
Amg 420 And Amg 701 In R/r Myeloma
2021
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise 6:52
Multiple Myeloma: Anti-bcma Bite Amg 701 Shows Preclinical P...
2020
MM: AMG 701 BiTE 3:57
Mm: Amg 701 Bite
2019
Novel bispecific T-cell engager molecule shows promise in r/r multiple myeloma 5:26
Novel Bispecific T-cell Engager Molecule Shows Promise In R/...
2021
Phase 1 Study of Anito-cel an Anti-BCMA CAR-T for RRMM | Michael Bishop | #ASH24 3:49
Phase 1 Study Of Anito-cel An Anti-bcma Car-t For Rrmm | Mic...
2024
Multiple myeloma highlights from ASH 2020 3:59
Multiple Myeloma Highlights From Ash 2020
2021
Phase 1 Results of Teclistamab, BCMA 2:21
Phase 1 Results Of Teclistamab, Bcma
2020
BiTEs for the treatment of multiple myeloma 11:06
Bites For The Treatment Of Multiple Myeloma
2021
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.